health economics and health care management

Font size »A . A+ . A++ .

RESEARCH GROUP "TRANSLATIONAL HEALTH ECONOMICS":

Portait Wolf Rogowski

Postal address:

Helmholtz Zentrum München
German Research Center for Environmental Health
Institute of Health Economics and Health Care Management (IGM)
P.O.Box 1129
D-85758 Neuherberg
Germany
Tel.: +49-89 / 3187-4128
Fax: +49-89 / 3187-194128
eMail: rogowski(at)helmholtz-muenchen.de 

 

Dr. Wolf Rogowski, economist (Dipl.-Kaufmann)

Position:

Head of the Research Group 1

 

 

Education:

  • 2007s: Ph.D. on “Issues in the economic evaluation of gene technology in health care” at LUDWIG MAXIMILIANS UNIVERSITY (LMU) Munich, Germany
  • 2002s – 2005s: Master of Business Research at LMU Munich, Germany
  • 2000w – 2002s: Scholarship for the Center for Digital Technology and Management (LMU) Munich, Germany
  • 1999w – 2000s: Exchange studies at ERASMUS UNIVERSITY Rotterdam, Netherlands
  • 1998w – 2002s: Graduate studies in business administration (innovation research and technology management) at LMU Munich, Germany
  • Summer term 1997 – 1998s: Undergraduate studies in Economics at KARL-RUPRECHTS UNIVERSITÄT Heidelberg, Germany
  • Winter term 1996: Propaedeutic course of ethics and theology at HERMANNSBURG COLLEGE OF THEOLOGY  Hermannsburg, Germany

 

Work:

  • May – October 2007: visiting researcher at the TEEHTA, Centre for Health Economics, UNIVERSITY OF YORK YORK, United Kingdom
  • October 2002 – October 2003: project controller at XANTOS BIOMEDICINE AG Martinsried, Germany
  • August 2001  – March 2002: teaching assistant at  ODEON CENTER FOR ENTREPRENEURSHIP (LMU) Munich, Germany
  • March – September 1999: research assistant at SEMINAR FOR INTERNATIONAL ECONOMICS (LMU) Munich, Germany
  • August – September 1998: NATIONAL UNIVERSITY OF MONGOLIA Ulan Bator, Mongolia

 

Research interests:

  • Decision making about medical innovation in theory and practice:
    • Decision analytic cost-effectiveness and value of information analysis
    • Ethical principles for prioritization in health care
    • Comparative analysis of fourth hurdle institutions

 

Current research projects:

  • Fair and reasonable prioritization of genetics services (collaboration with EuroGentest Unit 3).
    EuroGentest is an EU-funded Network of Excellence (NoE) with 5 Units looking at all aspects of genetic testing - Quality Management, Information Databases, Public Health, New Technologies and Education. Through a series of initiatives EuroGentest encourages the harmonization of standards and practice in all these areas throughout the EU and beyond. This subproject develops a model for fair and reasonable prioritization of genetics services.
  • Early economic evaluation of innovative medical technologies in the framework of the project REGiNA (Sub-project 17)
    REGiNA stands for the concept of a centre of applied regenerative medicine (RegMed) in the region between Stuttgart, Tübingen and Necker-Alb (Federal state of Baden-Württemberg). The aim of the project is to promote innovative products and processes by introducing them to the health care system on a test basis. Sub-project 17 is concerned with the health economic aspects of regenerative medicine. In particular it is researched in how far the early economic evaluation of technologies developed in the framework of the REGiNA project can facilitate future market access and possibly influence the ongoing development process
  • Individualized Health Care: Ethical, Economic and Legal Implications for the German Health Care System (ELSA funding programme)
    Due to genetic and physiological variation, patients differ in their health risks, chances for curative treatment and reactions to specific drugs. In the future, it is expected that the prevention and treatment of diseases will be tailored more specifically to individual patients or patient groups. Decision-makers hope that this individualized approach will improve the quality and efficiency of health care. The current interdisciplinary project will consider problems related to  individualized health care from an ethical and legal as well as economic perspective, and the health economic analysis will be carried out at our institute.
  • International comparisons of processes for coverage decision making.
    Fourth hurdle institutions are internationally highly heterogeneous and the criteria used in decision practice are frequently unknown. Based on selected case studies particularly in the field of prevention and screening, this study compares different decision processes and outcomes across Europe.

 

  

Selected publications:

  • Fischer, K.E., Leidl, R., Rogowski, W.H.: A structured tool to analyse coverage decisions: development and feasibility test in the field of cancer screening and prevention. Health Policy 101(3), 290-299 (2011)
  • Rogowski, W., et al.: The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis. Health Technol Assess 13(31), 1-102 (2009)
  • Rogowski, W.H.: The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study. Med Decis Making 29(2), 224-38 (2009)
  • Rogowski, W.H., Grosse, S.D., Khoury, M.J.: Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet 10(7), 489-95 (2009)
  • Rogowski, W.H., Landauer, M., John, J.:Entscheidungsanalytische Modellierung von Kosten pro QALY im Kontext des deutschen Sozialrechts [Decision-analytical modelling of costs per QALY in the context of the German Social Law]. Gesundheitswesen 71(11), 739-50 (2009)
  • Langer, A., Rogowski, W.: Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res 9, 115 (2009)
  • Rogowski, W.H., Hartz, S.C., John, J.H.: Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine. BMC Health Serv Res 8(194), 1-12 (2008)
  • Hartz, S., Rogowski, W.: Entscheidungsprozesse über die Kostenerstattung für neue medizinische Verfahren in den USA [Coverage Procedures for New Medical Technologies in the USA]. Gesundheitsökonomie und Qualitätsmanagement 13, 345-357 (2008)
  • Rogowski, W.: Current impact of gene technology on healthcare. A map of economic assessments. Health Policy 80 (2), 340-357 (2007)
  • Rogowski, W.: Genetic screening by DNA technology. A systematic review of health economic evidence. International Journal of Technology Assessment in Health Care 22 (3), 327-337 (2006)

 

 

Teaching:

     

    Others:

     

    back to Team